Extracellular deoxyribonucleic acid (eDNA)

Extracellular deoxyribonucleic acid (**eDNA**) refers to DNA that exists outside the confines of living cells. It is found ubiquitously across biological systems—in microbial communities where it forms an essential structural component of biofilms,[2][3] in animal tissues where it participates in immune defense mechanisms such as neutrophil extracellular traps,[2] and even within plant root matrices.[1] In microbial ecosystems, eDNA stabilizes biofilm architecture by forming lattices with proteins,[2] facilitates horizontal gene transfer between organisms,[3] chelates cations thereby enhancing resistance to antibiotics,[3] and serves both protective structural roles and sources of nutrients.[4] In higher organisms—including humans—extracellular self-DNA acts as a **damage-associated molecular pattern** (**DAMP**), triggering innate immune responses when released during cell injury or death. This process is implicated in various inflammatory conditions including autoimmune diseases like systemic lupus erythematosus and rheumatoid arthritis; elevated levels are also observed in cancers, hypertension, Parkinson's disease, Alzheimer's disease, among others.[1] Although **eDNA** plays critical roles across biology—from ecological function to pathogenesis—it is not considered a conventional therapeutic target such as an enzyme or receptor. Instead therapies may aim at degrading eDNA using nucleases (like DNase I) particularly for disrupting bacterial biofilms or reducing harmful inflammation. There are no standard abbreviations beyond "eDNA," nor does this entity fit into classic molecular classification schemes used for drug targets. The term “extracellular deoxyribonucleic acid” describes its chemical nature rather than denoting any specific protein structure or pharmacological binding site. If you require structured data extraction from this information later on—for example mapping drugs that interact with components involved with eDNA—you would need context-specific details about those interacting proteins/enzymes rather than the nucleic acid itself.

Other names

Extracellular DNAeDNACell-free DNA (context-dependent)Exogenous DNA (context-dependent)

Drugs do not directly "target" eDNA; rather, nucleases like DNase I degrade it to disrupt biofilms or reduce inflammation.